How to build a due diligence findings and risk tracker for Series A Financing Rounds

Build a company-side Series A diligence tracker by turning document review results into evidence-backed decisions: what is wrong or unknown, why it matters to the financing, who must act, and what proves resolution. Reconcile capitalization and corporate records, test IP and commercial-contract findings against proposed representations, and distinguish disclosure from remediation and closing conditions. The deliverable is a controlled findings register that helps company counsel brief management, prepare disclosure schedules, and assign unresolved issues without treating every missing document as a closing blocker.

When to use this workflow

Use this workflow when a Series A term sheet or investor request list produces findings across legal, finance, people, and engineering teams. It suits company counsel coordinating investor diligence where seed instruments, equity records, and early contracting practices need reconciliation.

The scope is findings management, not the entire financing checklist. Include an approval, filing, or closing deliverable when a diligence issue makes it relevant; link routine completion tasks elsewhere.

This guide assumes a US private-company equity financing by a Delaware corporation. Other incorporation jurisdictions, offering exemptions, state notices, and regulated activities require separate analysis. Contract conclusions depend on actual language, governing law, and facts.

What you need

Start with the current term sheet, investor request list, proposed purchase agreement and disclosure schedules, restated charter, and related investor agreements. Identify versions and whether the financing contemplates multiple closings.

Collect evidence specific to the proposed representations and business:

• Corporate and equity records: charter history, board and stockholder actions, stock ledger, capitalization model, option records, SAFEs, notes, and side letters.
• IP and personnel records: founder, employee, and consultant agreements; invention assignments; material licenses; and records identifying contributors to core technology.
• Commercial records: significant customer and supplier agreements, amendments, schedules, and financing-sensitive restrictions, regardless of contract value.
• Business context: company entities, product dependencies, financing timetable, responsible employees, and proposed securities exemption.

Maintain a separate document index with stable IDs, dates, execution status, versions, and access classifications. Link amendments to base agreements. Each tracker citation should identify the reviewed document, not a folder containing indistinguishable drafts.

Use the template

Use the Series A Financing Rounds — Diligence findings tracker below. You can copy this table into your working document or spreadsheet. Keep one independently resolvable finding per row.

In Source / evidence, record document ID, version, clause or page, and execution status. For missing material, cite the request and records searched rather than inventing a document citation.

Separate observed facts from unresolved questions in Finding / uncertainty. Explain priority through financing impact, not just a color or label. Deal link / treatment identifies the proposed representation, schedule section, charter provision, or closing condition and whether the response is disclosure, correction, negotiation, or investigation.

Name an accountable person in Action / owner. Enter an agreed target date and dependency. Status / proof should distinguish investigation, action underway, decision required, resolved, and accepted residual risk. Record the evidence, reviewer, and decision date there or in a linked issue note.

Step by step

1. Set the review boundaries and decision rules

Confirm the entities, review period, document set, and financing drafts covered. Identify who can decide commercial questions, approve disclosures, and accept residual risk. Keep sensitive personnel material and internal legal analysis in appropriately restricted records; do not assume the investor should receive the entire tracker.

Agree priority criteria. Ownership uncertainty, an inaccurate issuance model, a key contract restriction, or an unsatisfied proposed condition may warrant immediate attention. Low contract value alone should not determine priority.

Record: topic, provisional priority and rationale, accountable owner, and relevant deal document. State what missing evidence could change the assessment.

2. Reconcile records before drawing conclusions

Compare the capitalization model with the stock ledger, equity approvals, executed investment instruments, and amendments. Trace discrepancies to individual issuances or conversion assumptions. Preserve the finding rather than silently repairing the spreadsheet.

Distinguish operative corporate rights from term-sheet summaries. Delaware §151(a) permits differing stock rights when expressed in the certificate or issuance resolutions adopted under express charter authority; it does not itself grant a particular investor preference or veto. Review the actual governing text. See DGCL §151(a). (delcode.delaware.gov)

Record: each discrepancy, conflicting sources, unresolved question, and reconciliation owner. Distinguish missing, unsigned, superseded, and unverified documents.

3. Convert observations into specific findings

Write an evidence statement followed by its uncertainty. “Assignment language is not present in the supplied executed consultant agreement” is more useful than “IP problem.” Determine whether another instrument addresses the issue and what work the contributor performed before assessing significance.

For commercial contracts, examine assignment and change-of-control language separately, including express financing triggers. Check IP ownership, exclusivity, termination, indemnities, liability limitations, and missing amendments.

Do not import an arbitrary monetary cutoff. The historical RPX purchase agreement §2.12(b) addresses specified monetary obligations alongside material IP licenses, product restrictions, and IP indemnities, subject to qualifications. It illustrates negotiated representation scope, not a universal diligence threshold. See RPX §2.12(b). (sec.gov)

Record: pinpoint evidence, business exposure, remaining factual question, and related issue IDs.

4. Connect findings to the financing documents

Test each finding against the proposed representation and disclosure qualifications. Identify the precise schedule section if disclosure is proposed. Keep disclosure and corrective action separate: determine whether either or both are necessary under the draft documents.

For capitalization findings, connect the issue to conversion mechanics, issuance records, and the closing capitalization model. Compare investor-rights provisions with the term sheet, distinguishing an unintended inconsistency from a commercial term management knowingly accepts.

Record: document version and section, proposed treatment, company position, and decision-maker. If investor agreement is needed, distinguish the company's request from the investor's actual response. Update the row when drafting changes alter the analysis.

5. Decide whether resolution affects closing

Classify the issue as requiring a pre-closing decision, proposed pre-closing remediation, disclosure or negotiation, or assigned later action. Base that classification on the transaction documents and company assessment, not a generic severity label.

Read conditions by beneficiary and applicable closing. RPX §4 illustrates conditions applicable at each closing and a limitation on waiver effectiveness against nonconsenting investors. Those are agreement-specific provisions, not assumed terms of another financing. See RPX §4. (sec.gov)

RPX §§4.1–4.3 also connect representation accuracy, performance, and an officer's compliance certificate. A drafted certificate therefore should not substitute for checking the underlying facts. See RPX §§4.1–4.3. (sec.gov)

Record: applicable closing, condition citation, required evidence, and any unresolved waiver-authority question.

6. Assign actions and verify responses

Assign each action to someone able to produce evidence or obtain a decision. Legal may draft an assignment, while engineering identifies the contributor's work and a business owner secures cooperation.

Compare responses with the original issue. A newly supplied agreement may cover a different entity, period, or scope of services. Preserve the original finding and add resolution history rather than rewriting the row as though no issue existed.

Record: named owner, target date, dependency, evidence received, reviewer, and remaining action. Split a row when a response resolves only part of the finding and separate decisions remain necessary.

7. Freeze a decision-ready version and hand off open items

Before the relevant signing or closing decision, reconcile the tracker with current financing drafts and disclosure schedules. Prepare a short summary of unresolved material issues, decisions requested, and evidence outstanding, preserving the full register behind it.

If diligence identifies a Regulation D notice question, verify the trigger rather than assuming funding starts the clock. SEC guidance describes Form D as due within 15 calendar days after first sale—the first investor's irrevocable contractual commitment—with a weekend or holiday adjustment. Review state requirements separately. See SEC Form D FAQ, question 1. (sec.gov)

Record: disposition, approving decision-maker, evidence link, and receiving owner for open work. Transfer follow-up tasks without marking unfinished remediation resolved.

Worked example

Entirely fictional scenario: Alder Circuit, Inc., a Delaware software company, is preparing a $9 million Series A. Its draft purchase agreement contains capitalization and IP representations. Investor counsel requests support for the conversion model, core-software ownership, and continued access to an important vendor service.

Company counsel reviews a workbook, executed seed note, consultant agreement, and vendor contract. All parties, documents, amounts, and provisions below are fictional. The supplied record contains no note amendment, separate assignment, or delivered vendor notice; that does not establish that none exists.

F-01 pauses approval of the capitalization schedule; it does not establish a corrected conversion result. F-02 calls for targeted evidence gathering rather than an unsupported conclusion that the company lacks ownership. F-03 requires notice analysis, not a consent request: the reviewed clause contains no consent requirement, but counsel must check amendments and related provisions before confirming the obligation.

The tracker changes the decision by identifying the next evidence needed and preventing a generic “high risk” designation from obscuring different responses.

Common mistakes

• Treating the data room as the findings record. Upload status does not explain significance. Create issue rows with evidence and decisions needed.
• Combining every equity discrepancy. Separate option approvals, conversion assumptions, and ledger mismatches so each has independent resolution proof.
• Equating disclosure with cure. Analyze disclosure and remediation separately against the proposed documents.
• Calling every financing-sensitive clause a consent right. Preserve the trigger and distinguish notice, consent, termination, assignment, and change of control.
• Closing rows when drafts arrive. Verify execution, scope, delivery, and underlying conditions before recording completion.

Final quality check

• Every material finding has a stable ID and verified pinpoint source, or a documented missing-record search.
• Facts, assumptions, legal analysis, and business decisions are distinguishable.
• Capitalization findings identify the model version and underlying instruments.
• Disclosure references match current financing drafts and schedules.
• Pre-closing classifications identify their contractual or decision basis.
• Resolved issues contain completion evidence and reviewer confirmation.
• Open issues and accepted residual risks have named owners, targets, dependencies, and decision records.
• The investor-facing extract contains only information approved for sharing.

Complete the workflow with DecoverAI

DecoverAI is the Legal Intelligence Platform for litigation and transactions. Its due diligence capabilities support bulk document classification to organize diligence and prioritize human review; tabular review supports work across multiple documents. In Word contract review, counsel can select the represented party and provide deal-specific instructions. Findings quote and locate clauses, rank severity, and identify missing language as not present. Lawyers retain responsibility for significance, disclosure, remediation, and resolution; the tracker remains the team's work product. To assess this workflow for a Series A document set, book a demo.

Frequently asked questions

Should the company share its entire tracker with investors?

Not by default. Maintain an internal register and prepare an approved external extract or response list. Review access restrictions and internal legal analysis before sharing. Preserve issue IDs so external answers remain traceable internally.

How should missing IP assignments be prioritized?

Start with the contributor's work, product significance, and available instruments. Identify the evidence gap and affected representation. A missing upload does not establish missing ownership, and confidentiality language should not be treated as assignment language.

Can one row cover all outstanding SAFEs and notes?

Only if instrument-level records remain traceable and the issue has one resolution. Separate findings where conversion terms, amendments, execution gaps, owners, or required decisions differ.

When is a finding ready to close?

When the stated action is complete, evidence is verified, and disclosure or drafting consequences are addressed. Document accepted residual risk separately: risk acceptance is a decision, not factual correction or proof of completed remediation.

Sources

• Delaware General Corporation Law, §151 — Delaware stock-rights framework.
• RPX Series A and A-1 Preferred Stock Purchase Agreement — historical examples of representation scope and closing conditions, not market standards.
• SEC Frequently Asked Questions and Answers on Form D — federal notice guidance.

This is general professional workflow guidance, not advice for a particular financing.

This guide is general information about legal workflows, not legal advice for any matter. It was drafted and reviewed with AI assistance. The worked example is fictional. Contract rights and procedure depend on the governing law, the actual wording, and the facts, so check the cited sources and the rules that apply in your jurisdiction before relying on it.